PYXTRIO
DEAD

Serial Number

79219212

Owner

NOVARTIS AG

Filing Date

Aug 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PYXTRIO Trademark

Serial Number: 79219212

PYXTRIO is a trademark filed by NOVARTIS AG on August 23, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 23, 2017

Registration Date

Not Registered

Published for Opposition

December 5, 2017

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

OPPOSITION TERMINATED NO. 999999
Sep 26, 2018 OP.T
OPPOSITION SUSTAINED NO. 999999
Aug 15, 2018 OP.S
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 28, 2018 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 27, 2018 DETH
REFUSAL PROCESSED BY IB
Jun 22, 2018 RFNP
OPPOSITION INSTITUTED NO. 999999
Jun 15, 2018 OP.I
OPPOSITION PAPERS RECEIVED AT TTAB
Jun 15, 2018 OPPF
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 14, 2018 ETOP
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Jun 5, 2018 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Jun 5, 2018 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 28, 2017 ETOF
PUBLISHED FOR OPPOSITION
Dec 5, 2017 PUBO
NOTICE OF PUBLICATION
Nov 15, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2017 CNSA
APPLICATION FILING RECEIPT MAILED
Oct 31, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 24, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 19, 2017 SDRC